XEN1101 is an experimental small molecule anticonvulsant and selective Kᵥ7.2/Kᵥ7.3 potassium channel opener being investigated as a treatment for refractory focal onset seizures and major depressive disorder. From Wikipedia
Despite not meeting primary endpoint, drug achieves statistical significance on several secondary endpoints, bolstering optimism for its potential in treating depression and other psychiatric conditions.
